2439. The role of positive externalities in economic evaluations of new antibiotics: modeling the impact of reduced transmission in healthcare facilities

BACKGROUND: Positive externalities - beneficial spillover effects enjoyed by individuals who are not the primary consumers of a good - are rarely considered in cost-effectiveness analyses (CEAs) of antimicrobial drugs that could reduce person-to-person transmission of the target pathogen. We develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Richard, Samore, Matthew H, Jernigan, John A, Slayton, Rachel, Toth, Damon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809678/
http://dx.doi.org/10.1093/ofid/ofz360.2117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809678/
http://dx.doi.org/10.1093/ofid/ofz360.2117

Ejemplares similares